| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |